19th week of 2022 patent applcation highlights part 12 |
Patent application number | Title | Published |
20220143133 | METHODS AND COMPOSITIONS FOR DIAGNOSIS AND PROGNOSIS OF RENAL INJURY AND RENAL FAILURE | 2022-05-12 |
20220143134 | A METHOD FOR TREATING DISEASE USING FOXP3+CD4+ T CELLS | 2022-05-12 |
20220143135 | INHIBITORS OF BCL-2 | 2022-05-12 |
20220143136 | USE OF ANNEXINS IN PREVENTING AND TREATING MUSCLE MEMBRANE INJURY | 2022-05-12 |
20220143137 | COMPOSITIONS AND METHODS FOR THE TREATMENT OF OCULAR NEOVASCULARIZATION | 2022-05-12 |
20220143138 | COMPOSITIONS FOR TREATING HEART DISEASE BY INHIBITING THE ACTION OF mAKAP-beta | 2022-05-12 |
20220143139 | Modulating Neuroinflammation | 2022-05-12 |
20220143140 | ANTI-CD6 ANTIBODY COMPOSITIONS AND METHODS FOR TREATING LUPUS | 2022-05-12 |
20220143141 | COMBINATIONS COMPRISING POSITIVE ALLOSTERIC MODULATORS OR ORTHOSTERIC AGONISTS OF METABOTROPIC GLUTAMATERGIC RECEPTOR SUBTYPE 2 AND THEIR USE | 2022-05-12 |
20220143142 | DIRECT REPROGRAMMING OF CARDIAC FIBROBLASTS INTO CARDIOMYOCYTES USING AN ENDOTHELIAL CELL TRANSDIFFERENTIATION STRATEGY | 2022-05-12 |
20220143143 | USE OF ACTIVATORS OF THE ARYL HYDROCARBON RECEPTOR FOR TREATING GLUTEN-INDUCED GASTROINTESTINAL DISEASES | 2022-05-12 |
20220143144 | TREATMENT INVOLVING INTERLEUKIN-2 (IL2) AND INTERFERON (IFN) | 2022-05-12 |
20220143145 | THERAPEUTIC CROSSLINKING OF CYTOKINE RECEPTORS | 2022-05-12 |
20220143146 | PEPTIDE YY PHARMACEUTICAL FORMULATIONS, COMPOSITIONS, AND METHODS | 2022-05-12 |
20220143147 | INTRANASAL NEUROPEPTIDES FOR USE IN STRESS-RELATED IMPAIRMENTS | 2022-05-12 |
20220143148 | COMPOSITIONS AND METHODS FOR MODULATING CGRP SIGNALING TO REGULATE INTESTINAL INNATE LYMPHOID CELLS | 2022-05-12 |
20220143149 | GHRH ANTAGONISTS FOR USE IN A METHOD OF TREATING SARCOIDOSIS | 2022-05-12 |
20220143150 | GLUCAGON-LIKE PEPTIDE-1 (GLP-1) AGONIST ANALOG, PROCESS OF PREPARATION AND USES THEREOF | 2022-05-12 |
20220143151 | FUNCTIONAL FOODS COMPRISING DIAMINE OXIDASE AND USES THEREOF | 2022-05-12 |
20220143152 | USE OF PEPTIDE DERIVED FROM H-REV107 | 2022-05-12 |
20220143153 | COMPOSITIONS AND METHODS FOR TREATING ACNE | 2022-05-12 |
20220143154 | SEQUENCE SPECIFIC ANTIMICROBIALS | 2022-05-12 |
20220143155 | TREATMENT OF RETINITIS PIGMENTOSA USING ENGINEERED MEGANUCLEASES | 2022-05-12 |
20220143156 | LYSOZYME HYDROLYSATE FOR PROACTIVE INHIBITORY CONTROL AND CONTROL OF IMPULSIVITY | 2022-05-12 |
20220143157 | NOVEL USES OF BOTULINUM NEUROTOXIN FOR THE TREATMENT OF TREMOR | 2022-05-12 |
20220143158 | DUODENAL ADMINISTRATION OF BOTULINUM TOXIN | 2022-05-12 |
20220143159 | Cystatin C and Cystatin 9 to Treat Inflammation Caused by Bacteria | 2022-05-12 |
20220143160 | Compositions Comprising Apoptotic Signaling and Methods for Induction of Antigen-Specific Tolerance | 2022-05-12 |
20220143161 | MRNA VACCINE | 2022-05-12 |
20220143162 | NOVEL PEPTIDES AND COMBINATION OF PEPTIDES FOR USE IN IMMUNOTHERAPY AGAINST PROSTATE CANCER AND OTHER CANCERS | 2022-05-12 |
20220143163 | NOVEL PEPTIDES AND COMBINATION OF PEPTIDES FOR USE IN IMMUNOTHERAPY AGAINST PROSTATE CANCER AND OTHER CANCERS | 2022-05-12 |
20220143164 | NOVEL PEPTIDES AND COMBINATION OF PEPTIDES FOR USE IN IMMUNOTHERAPY AGAINST PROSTATE CANCER AND OTHER CANCERS | 2022-05-12 |
20220143165 | VACCINE COMPOSITIONS COMPRISING AN AMPHIPATHIC COMPOUND, A NEOANTIGEN AND A HYDROPHOBIC CARRIER, AND METHODS OF USE THEREOF | 2022-05-12 |
20220143166 | MULTIVALENT PNEUMOCOCCAL POLYSACCHARIDE-PROTEIN CONJUGATE VACCINE | 2022-05-12 |
20220143167 | SACCHARIDE-POLYPEPTIDE CONJUGATE COMPOSITIONS AND METHODS OF USE THEREOF | 2022-05-12 |
20220143168 | Vaccines targeting H. influenzae | 2022-05-12 |
20220143169 | METHOD OF CONFERRING A PROTECTIVE IMMUNE RESPONSE TO NOROVIRUS | 2022-05-12 |
20220143170 | COMPOSITIONS, METHODS AND USES FOR THERMALLY STABLE HUMAN PAPILLOMAVIRUS FORMULATIONS | 2022-05-12 |
20220143171 | CD40 LIGAND FUSION PROTEIN VACCINE | 2022-05-12 |
20220143172 | IMMUNE COMPOSITION COMPRISING ANTIGEN AND GLYCOENGINEERED ANTIBODY THEREOF | 2022-05-12 |
20220143173 | VIRUS-LIKE PARTICLES | 2022-05-12 |
20220143174 | MULTIVALENT KAPOSI SARCOMA-ASSOCIATED HERPESVIRUS-LIKE PARTICLES AND USES THEREOF | 2022-05-12 |
20220143175 | NOROVIRUS VACCINES | 2022-05-12 |
20220143176 | Substance for Treating and/or Preventing Intolerance Diseases, and Design Method and Preparation Method thereof | 2022-05-12 |
20220143177 | METHOD OF MODULATING MUCOSAL IMMUNOGENICITY | 2022-05-12 |
20220143178 | ANTI-HER2 BISPECIFIC ANTIBODY AND APPLICATION THEREOF | 2022-05-12 |
20220143179 | DRUG DELIVERY FOR COMBINATION OF EPIGENETIC MODULATION AND IMMUNE CHECKPOINT BLOCKADE | 2022-05-12 |
20220143180 | FORMULATION COMPRISING ANTI-CD47 ANTIBODY, PREPARATION METHOD THEREFOR AND USE THEREOF | 2022-05-12 |
20220143181 | FORMULATIONS OF HUMAN ANTI-RANKL ANTIBODIES, AND METHODS OF USING THE SAME | 2022-05-12 |
20220143182 | ACOUSTIC DRIVEN DRUG DELIVERY SYSTEMS | 2022-05-12 |
20220143183 | PHOTOSWITCHABLE PROTACS AND SYNTHESIS AND USES THEREOF | 2022-05-12 |
20220143184 | MITOCHONDRION/RIBONUCLEIC ACID-TARGETED AND MIGRATABLE PHOTOSENSITIZED PROBE AND APPLICATION THEREOF | 2022-05-12 |
20220143185 | ORALLY ACTIVE SMALL MOLECULE INHIBITOR OF PAI-1 | 2022-05-12 |
20220143186 | SOLIDIFICATION OR CRYSTALLISATION METHOD | 2022-05-12 |
20220143187 | PRESERVED FORMULATIONS | 2022-05-12 |
20220143188 | FORMULATION FOR ORAL DELIVERY OF PROTEINS, PEPTIDES AND SMALL MOLECULES WITH POOR PERMEABILITY | 2022-05-12 |
20220143189 | CARBOHYDRATE CONJUGATES AS DELIVERY AGENTS FOR OLIGONUCLEOTIDES | 2022-05-12 |
20220143190 | HYDROGEL COMPRISING HYALURONIC ACID MODIFIED BY SEROTONIN AND USES THEREOF | 2022-05-12 |
20220143191 | ADJUVANT BEVERAGE | 2022-05-12 |
20220143192 | COMPOSITIONS COMPRISING VITAMINS/MINERALS IN A POLYPHENOLIC MATRIX, METHODS AND USES THEREOF | 2022-05-12 |
20220143193 | TARGETED SENSITIZATION OF NON-DEL(5q) MALIGNANT CELLS | 2022-05-12 |
20220143194 | SELENIUM ANTIBODY CONJUGATES | 2022-05-12 |
20220143195 | BIFUNCTIONAL COMPOUNDS FOR DEGRADING BTK VIA UBIQUITIN PROTEOSOME PATHWAY | 2022-05-12 |
20220143196 | CONJUGATION OF MCR1 LIGAND WITH CYTOTOXIC DRUGS FOR TREATING SKIN CANCER | 2022-05-12 |
20220143197 | siRNA Inhibition Of Human Antigen R Expression For Treatment of Cancer | 2022-05-12 |
20220143198 | COMPOSITIONS AND METHODS RELATED TO TETHERED KETHOXAL DERIVATIVES | 2022-05-12 |
20220143199 | IMMOLATIVE CELL-PENETRATING COMPLEXES FOR NUCLEIC ACID DELIVERY TO THE LUNG | 2022-05-12 |
20220143200 | COMPOSITION OF POLYETHYLENE GLYCOL MALEIMIDE DERIVATIVE AND POLYMERIZATION INHIBITOR | 2022-05-12 |
20220143201 | COMPOSITION COMPRISING A POLYMERIC REAGENT | 2022-05-12 |
20220143202 | COMPOUNDS THAT PARTICIPATE IN COOPERATIVE BINDING AND USES THEREOF | 2022-05-12 |
20220143203 | NOVEL BIOMOLECULE CONJUGATES AND USES THEREFOR | 2022-05-12 |
20220143204 | INTERNALIZING BINDING MOLECULES TARGETING RECEPTORS INVOLVED IN CELL PROLIFERATION OR IN CELL DIFFERENTIATION | 2022-05-12 |
20220143205 | Anti-CD25 Antibody-Maytansine Conjugates and Methods of Use Thereof | 2022-05-12 |
20220143206 | MUSCLE TARGETING COMPLEXES AND USES THEREOF FOR TREATING DYSTROPHINOPATHIES | 2022-05-12 |
20220143207 | BINDING MOLECULES SPECIFIC FOR HBV ENVELOPE PROTEIN | 2022-05-12 |
20220143208 | METHODS FOR INCREASING EFFICACY OF FOLR1 CANCER THERAPY | 2022-05-12 |
20220143209 | BETA-GLUCURONIDE-LINKER DRUG CONJUGATES | 2022-05-12 |
20220143210 | HYDROGEL COMPOSITIONS AND METHODS FOR TREATEMENT OF MALIGNANCIES | 2022-05-12 |
20220143211 | HYDROGELS AND METHODS OF USING THE SAME | 2022-05-12 |
20220143212 | MAMC-MEDIATED BIOMIMETIC NANOPARTICLES | 2022-05-12 |
20220143213 | Composition and Methods for Evading Humoral Immunity | 2022-05-12 |
20220143214 | SYSTEMS FOR EVOLVED ADENO-ASSOCIATED VIRUSES (AAVS) FOR TARGETED DELIVERY | 2022-05-12 |
20220143215 | GENE THERAPY VECTORS FOR TREATMENT OF DANON DISEASE | 2022-05-12 |
20220143216 | RECOMBINANT VECTORS COMPRISING ARYLSULFATASE A AND THEIR USES IN STEM CELL THERAPY FOR THE TREATMENT OF METACHROMATIC LEUKODYSTROPHY | 2022-05-12 |
20220143217 | NEUROPROTECTIVE GENE THERAPY TARGETING THE AKT PATHWAY | 2022-05-12 |
20220143218 | METHODS OF TREATING OR PREVENTING AGE-RELATED DISORDERS | 2022-05-12 |
20220143219 | METHODS OF TREATING AND DIAGNOSING EPILEPSY | 2022-05-12 |
20220143220 | COMPOSITIONS AND METHODS FOR MODULATING MYC TARGET PROTEIN 1 | 2022-05-12 |
20220143221 | Gene Therapy For Eye Pathologies | 2022-05-12 |
20220143222 | SUBCUTANEOUS AND INTRAMUSCULAR ADMINISTRATION OF PYRAZINE COMPOUNDS | 2022-05-12 |
20220143223 | COMPOSITION AND COMPOSITE | 2022-05-12 |
20220143224 | MRI CONTRAST AGENT FOR USE IN THE DIAGNOSIS OF EARLY CHANGES IN THE ENDOTHELIUM OF BLOOD VESSELS | 2022-05-12 |
20220143225 | ULTRAFINE IRON OXIDE NANOPARTICLE-BASED MAGNETIC RESONANCE IMAGING T1 CONTRAST AGENT | 2022-05-12 |
20220143226 | USE OF TRIAZOLO[4,5-D]PYRIMIDINE DERIVATIVES | 2022-05-12 |
20220143227 | Method of Treatment of Neuroendocrine Tumors That Over-Express Somatostatatin Receptors | 2022-05-12 |
20220143228 | HER3 RADIOIMMUNOTHERAPY FOR THE TREATMENT OF SOLID CANCERS | 2022-05-12 |
20220143229 | RADIO-PHARMACEUTICAL COMPLEXES | 2022-05-12 |
20220143230 | BIFUNCTIONAL do2pa DERIVATIVES, CHELATES WITH METALLIC CATIONS AND USE THEREOF | 2022-05-12 |
20220143231 | MACROCYCLIC COMPOUNDS AND METHODS OF USE THEREOF | 2022-05-12 |
20220143232 | METHOD AND APPARATUS FOR STERILIZING AND DISINFECTING AIR AND SURFACES AND PROTECTING A ZONE FROM EXTERNAL MICROBIAL CONTAMINATION | 2022-05-12 |